Skip to main content

Advertisement

Log in

Combining Bone Collagen Material with hUC-MSCs for Applicationto Spina Bifida in a Rabbit Model

  • Published:
Stem Cell Reviews and Reports Aims and scope Submit manuscript

Abstract

Spina bifida is one of the neural tube defects, with a high incidence in human birth defects, which seriously affects the health and quality of life of patients. In the treatment of bone defects, the source of autologous bone is limited and will cause secondary damage to the patient. At the same time, since the bone tissue in animals needs to play a variety of biological functions, its complex structure cannot be replaced by a single material. The combination of mechanical materials and biological materials has become a common choice. Human umbilical cord mesenchymal stem cells (hUC-MSCs) have the advantages of easy access, rapid proliferation, low immunogenicity, and no ethical issues. It is often used in the clinical research of tissue regeneration and repair. Therefore, in this study, we established a spina bifida model using Japanese white rabbits. This model was used to screen the best regenerative repair products for congenital spina bifida, and to evaluate the safety of regenerative repair products. The results showed that the combination of hUC-MSCs with collagen material had better regeneration effect than collagen material alone, and had no negative impact on the health of animals. This study provides a new idea for the clinical treatment of spina bifida, and also helps to speed up the research progress of regenerative repair products.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

Data Availability

All data generated or analyzed during this study are included in this published article.

References

  1. Adzick, N. S. (2010). Fetal myelomeningocele: Natural history, pathophysiology, and in-utero intervention. Seminars in Fetal and Neonatal Medicine, 15(1), 9–14.

    Article  PubMed  Google Scholar 

  2. McComb, J. G. (2015). A practical clinical classification of spinal neural tube defects. Childs Nervous System, 31(10), 1641–1657.

    Article  Google Scholar 

  3. Tortori-Donati, P., Rossi, A., & Cama, A. (2000). Spinal dysraphism: A review of neuroradiological features with embryological correlations and proposal for a new classification. Neuroradiology, 42(7), 471–491.

    Article  CAS  PubMed  Google Scholar 

  4. Atta, C. A., et al. (2016). Global Birth Prevalence of Spina Bifida by Folic Acid Fortification Status: A Systematic Review and Meta-Analysis. American Journal of Public Health, 106(1), 24–34.

    Article  Google Scholar 

  5. Liu, J., et al. (2016). Prevalence and trend of neural tube defects in five counties in Shanxi province of Northern China, 2000 to 2014. Birth Defects Research. Part A, Clinical and Molecular Teratology, 106(4), 267–274.

    Article  CAS  PubMed  Google Scholar 

  6. Wang, W., & Yeung, K. (2017). Bone grafts and biomaterials substitutes for bone defect repair: A review. Bioact Mater, 2(4), 224–247.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Kim, S. Y., et al. (2012). An early comparative analysis of the use of autograft versus allograft in anterior cervical discectomy and fusion. Korean J Spine, 9(3), 142–146.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Scheerlinck, L. M., et al. (2013). Donor site complications in bone grafting: Comparison of iliac crest, calvarial, and mandibular ramus bone. International Journal of Oral and Maxillofacial Implants, 28(1), 222–227.

    Article  PubMed  Google Scholar 

  9. Thrivikraman, G., et al. (2017). Biomaterials for Craniofacial Bone Regeneration. Dental Clinics of North America, 61(4), 835–856.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Fan, Q., et al. (2021). Ridge preservation of a novel extraction socket applying Bio-Oss(R) collagen: An experimental study in dogs. Journal of Dental Sciences, 16(3), 831–839.

  11. Pham, P. V., Vu N. B. (2020). Off-the-shelf mesenchymal stem cells from human umbilical cord tissue can significantly improve symptoms in COVID-19 patients: An analysis of evidential relations. World Journal of Stem Cells, 12(8), 721–730.

  12. Deng, W. S., et al. (2020). Collagen scaffold combined with human umbilical cord-mesenchymal stem cells transplantation for acute complete spinal cord injury. Neural Regeneration Research, 15(9), 1686–1700.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Qu, Q., et al. (2020). Exosomes derived from human umbilical cord mesenchymal stem cells inhibit vein graft intimal hyperplasia and accelerate reendothelialization by enhancing endothelial function. Stem Cell Research & Therapy, 11(1), 133.

  14. Bielby, R., Jones, E., McGonagle, D. (2007). The role of mesenchymal stem cells in maintenance and repair of bone. Injury, 38(1), S26–32.

  15. Zhang, Y., Husch, J., & van den Beucken, J. (2018). Intraoperative Construct Preparation: A Practical Route for Cell-Based Bone Regeneration. Tissue Engineering. Part B, Reviews, 24(5), 403–417.

    Article  PubMed  Google Scholar 

  16. Baranovskii, D. S., et al. (2022). Minimally Manipulated Bone Marrow-Derived Cells Can Be Used for Tissue Engineering In Situ and Simultaneous Formation of Personalized Tissue Models. Bulletin of Experimental Biology and Medicine, 173(1), 139–145.

    Article  CAS  PubMed  Google Scholar 

  17. Chen, B., et al. (2007). Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2. Biomaterials, 28(6), 1027–35.

  18. Zhang, L., et al. (2018). Therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase. Stem Cell Research & Therapy, 9(1), 36.

  19. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I.,Marini, F., Krause, D., Deans, R., Keating, A., Dj, P., & Horwitz, E. (2006). Minimal criteria for defining multipotent mesenchymalstromal cells. The International Society for Cellular Therapy positionstatement. Cytotherapy, 8(4), 315–317.

  20. Werler, M. M., Shapiro, S., Mitchell, A. A. (1993). Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA, 269(10), 1257–1261.

  21. Finnell, R.H., et al. (2021). Gene Environment Interactions in the Etiology of Neural Tube Defects. Frontiers in Genetics, 12, 659612.

  22. Greene, N. D., Copp, A. J. (2009) Development of the vertebrate central nervous system: formation of the neural tube. Prenatal Diagnosis, 29(4), 303–311.

  23. El-Sherbiny, M., et al. (2020). Functional beta-cells derived from umbilical cord blood mesenchymal stem cells for curing rats with streptozotocin-induced diabetes mellitus. Singapore Medical Journal, 61(1), 39–45.

  24. Feng, Y., et al. (2020). Effects of human umbilical cord mesenchymal stem cells derived from exosomes on migration ability of endometrial glandular epithelial cells. Molecular Medicine Reports, 22(2), 715–722.

  25. Guo, Z., et al. (2020). Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia. Critical Care, 24(1), 420.

  26. Lin, M. J., et al. (2020). Plasma membrane vesicles of human umbilical cord mesenchymal stem cells ameliorate acetaminophen-induced damage in HepG2 cells: a novel stem cell therapy. Stem Cell Research & Therapy, 11(1), 225.

  27. Liu, A. M., et al. (2020). Human adipose tissue- and umbilical cord-derived stem cells: which is a better alternative to treat spinal cord injury? Neural Regeneration Research, 15(12), 2306–2317.

  28. Jerkic, M., et al. (2020). Human Umbilical Cord Mesenchymal Stromal Cells Attenuate Systemic Sepsis in Part by Enhancing Peritoneal Macrophage Bacterial Killing via Heme Oxygenase-1 Induction in Rats. Anesthesiology, 132(1), 140–154.

  29. Jia, Z., Wang, S., Liu, Q. (2020). Identification of differentially expressed genes by single-cell transcriptional profiling of umbilical cord and synovial fluid mesenchymal stem cells. Journal of Cellular and Molecular Medicine, 24(2), 1945–1957.

  30. An, J. H., et al. (2013). Transplantation of human umbilical cord blood-derived mesenchymal stem cells or their conditioned medium prevents bone loss in ovariectomized nude mice. Tissue Engineering Part A, 19(5–6), 685–696.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Hendrijantini, N., et al. (2018). A potential therapy of human umbilical cord mesenchymal stem cells for bone regeneration on osteoporotic mandibular bone. European Journal of Dental Education, 12(3), 358–362.

    Article  Google Scholar 

  32. Zhang, S., et al. (2016). Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration. Osteoarthritis Cartilage, 24(12), 2135–2140.

    Article  CAS  PubMed  Google Scholar 

  33. Tomasoni, S., et al. (2013). Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cells and Development, 22(5), 772–780.

    Article  CAS  PubMed  Google Scholar 

  34. Furuta, T., et al. (2016). Mesenchymal Stem Cell-Derived Exosomes Promote Fracture Healing in a Mouse Model. Stem Cells Translational Medicine, 5(12), 1620–1630.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Qin, Y., et al. (2016). Bone marrow stromal/stem cell-derived extracellular vesicles regulate osteoblast activity and differentiation in vitro and promote bone regeneration in vivo. Science and Reports, 6, 21961.

    Article  CAS  Google Scholar 

  36. Liu, J., et al. (2013). Acellular spinal cord scaffold seeded with mesenchymal stem cells promotes long-distance axon regeneration and functional recovery in spinal cord injured rats. Journal of the Neurological Sciences, 25(1–2), 127–136.

    Article  Google Scholar 

  37. Bamba, Y., et al. (2017). Generation of Induced Pluripotent Stem Cells and Neural Stem/Progenitor Cells from Newborns with Spina Bifida Aperta. Asian Spine J, 11(6), 870–879.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors are very grateful to the animal experiment center of the National Research Institute for Family Planning for its meticulous care of animals.

Funding

The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by grants from the National Key Research and Development Program of China [2016YFC1000803].

Author information

Authors and Affiliations

Authors

Contributions

XCS, XM and HFX designed the study. HW, XCSand JHL were responsible for the vivo surgery. XCS and HW were responsible for in vitro experiments. HW,XCS and HFX prepared the manuscript. YFY and LQY provided the bone repair materials and collagen membranes. HW, XCS, JHL and HFX were responsible for revising the manuscript critically for important intellectual content. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Xu Ma or Hong-Fei Xia.

Ethics declarations

Conflict of Interest

The authors declare that they have no competinginterests.

Ethical Approval

Ethical approval to report this case was obtained fromthe National Research Institute for Family Planning (Ethics Number2015-16).

Consent for Publication

All authors gave consent for publication.

Informed Consent

There are no human subjects in this article andinformed consent is not applicable.

Research involving Human and Animal Rights

All procedures in thisstudy were conducted in accordance with the National Research Institutefor Family Planning (Ethics Number 2015–16) approved protocols.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, H., Sun, XC., Li, JH. et al. Combining Bone Collagen Material with hUC-MSCs for Applicationto Spina Bifida in a Rabbit Model. Stem Cell Rev and Rep 19, 1034–1050 (2023). https://doi.org/10.1007/s12015-022-10478-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12015-022-10478-x

Keywords

Navigation